258 related articles for article (PubMed ID: 28215616)
1. Incidence and Determinants of Hepatocellular Carcinoma in Autoimmune Hepatitis: A Systematic Review and Meta-analysis.
Tansel A; Katz LH; El-Serag HB; Thrift AP; Parepally M; Shakhatreh MH; Kanwal F
Clin Gastroenterol Hepatol; 2017 Aug; 15(8):1207-1217.e4. PubMed ID: 28215616
[TBL] [Abstract][Full Text] [Related]
2. Sex and regional disparities in incidence of hepatocellular carcinoma in autoimmune hepatitis: a systematic review and meta-analysis.
Yan LJ; Yao SY; Meng GX; Liu KX; Li HC; Ding ZN; Dong ZR; Hong JG; Chen ZQ; Li T
Hepatol Int; 2021 Dec; 15(6):1413-1420. PubMed ID: 34478116
[TBL] [Abstract][Full Text] [Related]
3. Incidence and predictors of hepatocellular carcinoma in patients with autoimmune hepatitis.
Colapietro F; Maisonneuve P; Lytvyak E; Beuers U; Verdonk RC; van der Meer AJ; van Hoek B; Kuiken SD; Brouwer JT; Muratori P; Aghemo A; Carella F; van den Berg AP; Zachou K; Dalekos GN; Di Zeo-Sánchez DE; Robles M; Andrade RJ; Montano-Loza AJ; van den Brand FF; Slooter CD; Macedo G; Liberal R; de Boer YS; Lleo A; ;
J Hepatol; 2024 Jan; 80(1):53-61. PubMed ID: 37802188
[TBL] [Abstract][Full Text] [Related]
4. Hepatocellular carcinoma in patients with autoimmune hepatitis.
Teufel A; Weinmann A; Centner C; Piendl A; Lohse AW; Galle PR; Kanzler S
World J Gastroenterol; 2009 Feb; 15(5):578-82. PubMed ID: 19195059
[TBL] [Abstract][Full Text] [Related]
5. Development of hepatocellular carcinoma in autoimmune hepatitis patients: a case series.
Wong RJ; Gish R; Frederick T; Bzowej N; Frenette C
Dig Dis Sci; 2011 Feb; 56(2):578-85. PubMed ID: 21046244
[TBL] [Abstract][Full Text] [Related]
6. Cancer Risk in Patients With Autoimmune Hepatitis: A Nationwide Population-Based Cohort Study With Histopathology.
Sharma R; Verna EC; Simon TG; Söderling J; Hagström H; Green PHR; Ludvigsson JF
Am J Epidemiol; 2022 Jan; 191(2):298-319. PubMed ID: 33913487
[TBL] [Abstract][Full Text] [Related]
7. Evaluation of risk factors in the development of hepatocellular carcinoma in autoimmune hepatitis: Implications for follow-up and screening.
Yeoman AD; Al-Chalabi T; Karani JB; Quaglia A; Devlin J; Mieli-Vergani G; Bomford A; O'Grady JG; Harrison PM; Heneghan MA
Hepatology; 2008 Sep; 48(3):863-70. PubMed ID: 18752332
[TBL] [Abstract][Full Text] [Related]
8. Risk factors for hepatocellular carcinoma in Japanese patients with autoimmune hepatitis type 1.
Hino-Arinaga T; Ide T; Kuromatsu R; Miyajima I; Ogata K; Kuwahara R; Hisamochi A; Torimura T; Sata M;
J Gastroenterol; 2012 May; 47(5):569-76. PubMed ID: 22187167
[TBL] [Abstract][Full Text] [Related]
9. Older Age and Disease Duration Are Highly Associated with Hepatocellular Carcinoma in Patients with Autoimmune Hepatitis.
Dakhoul L; Jones KR; Gawrieh S; Ghabril M; McShane C; Vuppalanchi R; Vilar-Gomez E; Nephew L; Chalasani N; Lammert C
Dig Dis Sci; 2019 Jun; 64(6):1705-1710. PubMed ID: 30617453
[TBL] [Abstract][Full Text] [Related]
10. Epidemiology and clinical characteristics of autoimmune hepatitis in the Netherlands.
van Gerven NM; Verwer BJ; Witte BI; van Erpecum KJ; van Buuren HR; Maijers I; Visscher AP; Verschuren EC; van Hoek B; Coenraad MJ; Beuers UH; de Man RA; Drenth JP; den Ouden JW; Verdonk RC; Koek GH; Brouwer JT; Guichelaar MM; Vrolijk JM; Mulder CJ; van Nieuwkerk CM; Bouma G;
Scand J Gastroenterol; 2014 Oct; 49(10):1245-54. PubMed ID: 25123213
[TBL] [Abstract][Full Text] [Related]
11. Incidence of Hepatocellular Carcinoma in Primary Biliary Cholangitis: A Systematic Review and Meta-Analysis.
Natarajan Y; Tansel A; Patel P; Emologu K; Shukla R; Qureshi Z; El-Serag HB; Thrift AP; Kanwal F
Dig Dis Sci; 2021 Jul; 66(7):2439-2451. PubMed ID: 32743773
[TBL] [Abstract][Full Text] [Related]
12. Features of hepatocellular carcinoma in cases with autoimmune hepatitis and primary biliary cirrhosis.
Watanabe T; Soga K; Hirono H; Hasegawa K; Shibasaki K; Kawai H; Aoyagi Y
World J Gastroenterol; 2009 Jan; 15(2):231-9. PubMed ID: 19132775
[TBL] [Abstract][Full Text] [Related]
13. Risk factors for cancer in patients with primary biliary cholangitis and autoimmune hepatitis and primary biliary cholangitis overlap syndrome.
Braga MH; Cançado GGL; Bittencourt PL; Couto CA; Guedes LV; Lima AMC; Ferraz MLG; Villela-Nogueira CA; Nardelli MJ; Faria LC; Gomes NMF; Oliveira EMG; Rotman V; Oliveira MB; da Cunha SMCF; Cunha-Silva M; Mendes LSC; Ivantes CAP; Codes L; de Almeida E Borges VF; Pace FHL; Pessoa MG; Signorelli IV; Coral GP; Filho JG; Chagas AL; Terrabuio DRB; Cançado ELR;
Ann Hepatol; 2023; 28(4):101105. PubMed ID: 37088418
[TBL] [Abstract][Full Text] [Related]
14. Hepatic and Extrahepatic Characteristics of Autoimmune Hepatitis: A 23-year Hospital-Based Cohort Study.
Chang ML; Le PH; Chen WT; Chen TD; Chien RN
Dig Dis Sci; 2024 Jun; 69(6):2193-2203. PubMed ID: 38653947
[TBL] [Abstract][Full Text] [Related]
15. Hepatocellular carcinoma in patients with autoimmune hepatitis - a systematic review of the literature published between 1989-2016.
Valean S; Acalovschi M; Dumitrascu DL; Ciobanu L; Nagy G; Chira R
Med Pharm Rep; 2019 Apr; 92(2):99-105. PubMed ID: 31086834
[TBL] [Abstract][Full Text] [Related]
16. Clinical features of hepatocellular carcinoma in patients with autoimmune hepatitis in Japan.
Ohira H; Abe K; Takahashi A; Zeniya M; Ichida T
J Gastroenterol; 2013 Jan; 48(1):109-14. PubMed ID: 22688407
[TBL] [Abstract][Full Text] [Related]
17. Risk of hepatocellular carcinoma in antiviral treatment-naïve chronic hepatitis B patients treated with entecavir or tenofovir disoproxil fumarate: a network meta-analysis.
Huang ZH; Lu GY; Qiu LX; Zhong GH; Huang Y; Yao XM; Liu XH; Huang SJ; Wu T; Yuan Q; Wang YB; Su YY; Zhang J; Xia NS
BMC Cancer; 2022 Mar; 22(1):287. PubMed ID: 35300634
[TBL] [Abstract][Full Text] [Related]
18. A nationwide study of autoimmune liver diseases in the Faroe Islands: Incidence, prevalence, and causes of death 2004 - 2021.
Nielsen KR; Midjord J; Johannesen HL; Grønbæk H
Int J Circumpolar Health; 2023 Dec; 82(1):2221368. PubMed ID: 37300838
[No Abstract] [Full Text] [Related]
19. Diabetes Mellitus Heightens the Risk of Hepatocellular Carcinoma Except in Patients With Hepatitis C Cirrhosis.
Yang JD; Mohamed HA; Cvinar JL; Gores GJ; Roberts LR; Kim WR
Am J Gastroenterol; 2016 Nov; 111(11):1573-1580. PubMed ID: 27527741
[TBL] [Abstract][Full Text] [Related]
20. Fibrosis Stage-specific Incidence of Hepatocellular Cancer After Hepatitis C Cure With Direct-acting Antivirals: A Systematic Review and Meta-analysis.
Kim NJ; Vutien P; Cleveland E; Cravero A; Ioannou GN
Clin Gastroenterol Hepatol; 2023 Jul; 21(7):1723-1738.e5. PubMed ID: 35525392
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]